These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 18630453)
1. Expression of thymidylate synthase in liver and lung metastases of colorectal cancer and their matched primary tumours. Ohrling K; Edler D; Hallström M; Ragnhammar P Anticancer Res; 2008; 28(3B):1741-7. PubMed ID: 18630453 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer. Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123 [TBL] [Abstract][Full Text] [Related]
3. Thymidylate synthase protein expression in primary colorectal cancer compared with the corresponding distant metastases and relationship with the clinical response to 5-fluorouracil. Aschele C; Debernardis D; Tunesi G; Maley F; Sobrero A Clin Cancer Res; 2000 Dec; 6(12):4797-802. PubMed ID: 11156237 [TBL] [Abstract][Full Text] [Related]
4. Messenger RNA expression of TS and ERCC1 in colorectal cancer and matched liver metastasis. Kobayashi H; Sugihara K; Uetake H; Higuchi T; Yasuno M; Enomoto M; Iida S; Azuma M; Mori R; Omori A; Lenz HJ; Danenberg KD; Danenberg PV Int J Oncol; 2008 Dec; 33(6):1257-62. PubMed ID: 19020759 [TBL] [Abstract][Full Text] [Related]
6. Thymidylate synthase expression in primary colorectal tumours is correlated with its expression in metastases. Bendardaf R; Elzagheid A; Lamlum H; Algars A; Korkeila E; Ristamäki R; Collan Y; Syrjänen K; Pyrhönen S Scand J Gastroenterol; 2007 Apr; 42(4):471-6. PubMed ID: 17454857 [TBL] [Abstract][Full Text] [Related]
7. Detection of thymidylate synthase expression in lymph node metastases of colorectal cancer can improve the prognostic information. Ohrling K; Edler D; Hallström M; Ragnhammar P; Blomgren H J Clin Oncol; 2005 Aug; 23(24):5628-34. PubMed ID: 16009948 [TBL] [Abstract][Full Text] [Related]
8. Increased thymidylate synthase gene expression in liver metastases from colorectal carcinoma: implications for chemotherapeutic options and survival. Bathe OF; Franceschi D; Livingstone AS; Moffat FL; Tian E; Ardalan B Cancer J Sci Am; 1999; 5(1):34-40. PubMed ID: 10188059 [TBL] [Abstract][Full Text] [Related]
9. Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil. Cascinu S; Aschele C; Barni S; Debernardis D; Baldo C; Tunesi G; Catalano V; Staccioli MP; Brenna A; Muretto P; Catalano G Clin Cancer Res; 1999 Aug; 5(8):1996-9. PubMed ID: 10473077 [TBL] [Abstract][Full Text] [Related]
10. Thymidylate synthase and p53 expression in primary tumor do not predict chemotherapy outcome in metastatic colorectal carcinoma. Berglund A; Edler D; Molin D; Nordlinder H; Graf W; Glimelius B Anticancer Res; 2002; 22(6B):3653-9. PubMed ID: 12552972 [TBL] [Abstract][Full Text] [Related]
11. Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis. Inokuchi M; Uetake H; Shirota Y; Yamada H; Tajima M; Sugihara K Cancer Chemother Pharmacol; 2004 May; 53(5):391-6. PubMed ID: 15060742 [TBL] [Abstract][Full Text] [Related]
12. Thymidylate synthase gene promoter polymorphisms are associated with TSmRNA expressions but not with microsatellite instability in colorectal cancer. Calascibetta A; Cabibi D; Martorana A; Sanguedolce G; Rausa L; Feo S; Dardanoni G; Sanguedolce R Anticancer Res; 2004; 24(6):3875-80. PubMed ID: 15736425 [TBL] [Abstract][Full Text] [Related]
13. 5-Fluorouracil-related gene expression in primary sites and hepatic metastases of colorectal carcinomas. Sameshima S; Tomozawa S; Kojima M; Koketsu S; Motegi K; Horikoshi H; Okada T; Kon Y; Sawada T Anticancer Res; 2008; 28(3A):1477-81. PubMed ID: 18630501 [TBL] [Abstract][Full Text] [Related]
14. Decreased folylpolyglutamate synthetase activity in tumors resistant to fluorouracil-folinic acid treatment: clinical data. Chazal M; Cheradame S; Formento JL; Francoual M; Formento P; Etienne MC; François E; Richelme H; Mousseau M; Letoublon C; Pezet D; Cure H; Seitz JF; Milano G Clin Cancer Res; 1997 Apr; 3(4):553-7. PubMed ID: 9815719 [TBL] [Abstract][Full Text] [Related]
15. Expression level of thymidylate synthase mRNA reflects 5-fluorouracil sensitivity with low dose and long duration in primary colorectal cancer. Okumura K; Mekata E; Shiomi H; Naitoh H; Abe H; Endo Y; Kurumi Y; Tani T Cancer Chemother Pharmacol; 2008 Apr; 61(4):587-94. PubMed ID: 17520254 [TBL] [Abstract][Full Text] [Related]
16. Predictive value of thymidylate synthase expression in resected metastases of colorectal cancer. Corsi DC; Ciaparrone M; Zannoni G; Mancini M; Cassano A; Specchia M; Pozzo C; Martini M; Barone C Eur J Cancer; 2002 Mar; 38(4):527-34. PubMed ID: 11872345 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of thymidylate synthase in colorectal tumors and matched lymph nodes: impact on adjuvant treatment. Trocha SD; Saha SS; Wiese D; Thompson J; Morton DL; Bilchik AJ Am Surg; 2003 Oct; 69(10):918-22. PubMed ID: 14570375 [TBL] [Abstract][Full Text] [Related]
18. Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma. Wong NA; Brett L; Stewart M; Leitch A; Longley DB; Dunlop MG; Johnston PG; Lessells AM; Jodrell DI Br J Cancer; 2001 Dec; 85(12):1937-43. PubMed ID: 11747337 [TBL] [Abstract][Full Text] [Related]
19. Thymidylate synthetase mRNA levels are increased in liver metastases of colorectal cancer patients resistant to fluoropyrimidine-based chemotherapy. Libra M; Navolanic PM; Talamini R; Cecchin E; Sartor F; Tumolo S; Masier S; Travali S; Boiocchi M; Toffoli G BMC Cancer; 2004 Mar; 4():11. PubMed ID: 15040806 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy. Kamoshida S; Matsuoka H; Ishikawa T; Maeda K; Shimomura R; Inada K; Tsutsumi Y Jpn J Clin Oncol; 2004 Oct; 34(10):594-601. PubMed ID: 15591457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]